These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8429118)

  • 1. Antipyrine kinetics in patients with primary biliary cirrhosis.
    von Moltke LL; Abernethy DR; Kaplan MM; Greenblatt DJ
    J Clin Pharmacol; 1993 Jan; 33(1):75-7. PubMed ID: 8429118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipyrine clearance and metabolite formation in primary biliary cirrhosis.
    Jorquera F; Almar M; Linares A; Olcóz JL; Rodrigo L; González-Gallego J
    Dig Dis Sci; 2001 Feb; 46(2):352-9. PubMed ID: 11281185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between rifamycin-SV (R-SV) related hyperbilirubinaemia and antipyrine clearance as a new test of liver function in cirrhosis.
    Persico M; Romano M; Villano N; Montella F; Gentile S
    Eur J Clin Invest; 1994 Mar; 24(3):201-4. PubMed ID: 8033955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis.
    Wensing G; Hoffmann K; Heidemann HT
    Z Gastroenterol; 1993 Jan; 31(1):15-9. PubMed ID: 8447150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of antipyrine clearance in humans by propranolol.
    Greenblatt DJ; Franke K; Huffman DH
    Circulation; 1978 Jun; 57(6):1161-64. PubMed ID: 639239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of antipyrine in vivo in two rat models of liver cirrhosis. Its relationship to intrinsic clearance in vitro and microsomal membrane lipid composition.
    Buters JT; Zysset T; Reichen J
    Biochem Pharmacol; 1993 Sep; 46(6):983-91. PubMed ID: 8216358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic parameters of antipyrine in dog after hepatectomy.
    Galtier M; Briand D; Pinguet F; Gomeni R; Fabre D; Bressolle F
    Biopharm Drug Dispos; 1995 Nov; 16(8):669-84. PubMed ID: 8573686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis.
    Bauer LA; O'Sullivan T; Reiss WG; Horn JR; Opheim K; Strandness DE; Carithers RL
    Br J Clin Pharmacol; 1994 Apr; 37(4):375-81. PubMed ID: 8018459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis.
    Hoensch HP; Balzer K; Dylewizc P; Kirch W; Goebell H; Ohnhaus EE
    Eur J Clin Pharmacol; 1985; 28(4):475-7. PubMed ID: 4029252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipyrine pharmacokinetics in women receiving conjugated estrogens.
    Scavone JM; Greenblatt DJ; Blyden GT
    J Clin Pharmacol; 1988 May; 28(5):463-6. PubMed ID: 3392245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
    Branch RA; James JA; Read AE
    Clin Pharmacol Ther; 1976 Jul; 20(1):81-9. PubMed ID: 1277728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine disposition.
    Greenblatt DJ; Divoll MK; Abernethy DR; Ochs HR; Harmatz JS; Shader RI
    Pharmacology; 1989; 38(5):327-34. PubMed ID: 2762375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study of indocyanine green clearance in primary biliary cirrhosis.
    Clements D; Elias E; McMaster P
    Scand J Gastroenterol; 1991 Jan; 26(1):119-23. PubMed ID: 2006392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression.
    Coverdale SA; Samarasinghe DA; Lin R; Kench J; Byth K; Khan MH; Crewe E; Liddle C; George J; Farrell GC
    Am J Gastroenterol; 2003 Jun; 98(6):1384-90. PubMed ID: 12818285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinidine disposition in relation to antipyrine elimination and debrisoquine phenotype in alcoholic patients with and without cirrhosis.
    Debruyne D; Gram LF; Grollier G; Camsonne R; Agron L; Dao MT; Lacotte J; Bigot MC; Moulin M
    Int J Clin Pharmacol Res; 1989; 9(5):319-25. PubMed ID: 2625371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipyrine elimination as a dynamic test of hepatic functional integrity in obstructive jaundice.
    McPherson GA; Benjamin IS; Boobis AR; Brodie MJ; Hampden C; Blumgart LH
    Gut; 1982 Sep; 23(9):734-8. PubMed ID: 7106619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of primary biliary liver cirrhosis with rifampicin].
    Loginov AS; Reshetniak VI; Petrakov AV
    Ter Arkh; 1993; 65(8):57-62. PubMed ID: 8211805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
    Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
    J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of antipyrine metabolism by low-dose oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ
    Clin Pharmacol Ther; 1981 Jan; 29(1):106-10. PubMed ID: 7460468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.